Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108159 · ClinicalTrials.gov registry record
Integrated Whole-Genome Analysis of Hematologic Disorders
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 35
- Enrollment target
NCT01108159: Completed study, sponsored by Stanford University.
NCT01108159 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01108159 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.
Interventions
- PROCEDURE Blood Draw
- PROCEDURE Skin Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-08-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01108159
The ClinicalTrials.gov registry entry for NCT01108159 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Draw is the first listed.
NCT01108159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01108159 about?
NCT01108159 is a clinical study titled "Integrated Whole-Genome Analysis of Hematologic Disorders". We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and ...
What is the current status of trial NCT01108159?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2009-09. Estimated completion is 2013-08-02.
What interventions are being tested in trial NCT01108159?
The interventions under investigation include: Blood Draw (PROCEDURE), Skin Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01108159?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.